Announcing a new article publication for Cardiovascular Innovations and Applications journal. Atrial fibrillation is the most common arrhythmia worldwide, affecting millions of the general population.
Redox CEO Steps Down, Appoints Trip Hofer as New CEO
Trip Hofer, CEO at Redox What You Should Know: – Redox CEO and Co-Founder, Luke Bonney announced that he is stepping down as CEO and